Loading…

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls

Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Obje...

Full description

Saved in:
Bibliographic Details
Published in:Brain sciences 2022-10, Vol.12 (11), p.1430
Main Authors: Schinke, Christian, Rullmann, Michael, Luthardt, Julia, Drabe, Mandy, Preller, Elisa, Becker, Georg A., Patt, Marianne, Regenthal, Ralf, Zientek, Franziska, Sabri, Osama, Then Bergh, Florian, Hesse, Swen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c350t-3e5301ce9c688c20ab236686107923b9b96ca1fc1ff12fde7e05faf4c4182093
container_end_page
container_issue 11
container_start_page 1430
container_title Brain sciences
container_volume 12
creator Schinke, Christian
Rullmann, Michael
Luthardt, Julia
Drabe, Mandy
Preller, Elisa
Becker, Georg A.
Patt, Marianne
Regenthal, Ralf
Zientek, Franziska
Sabri, Osama
Then Bergh, Florian
Hesse, Swen
description Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Objective: To investigate the relation of HPA responsiveness and serotonin transporter (5-HTT) availability in otherwise healthy individuals with obesity class II or III (OB) compared to non-obesity controls (NO). Study participants: Twenty-eight OB (21 females; age 36.6 ± 10.6 years; body mass index (BMI) 41.2 ± 5.1 kg/m2) were compared to 12 healthy NO (8 females; age 35.8 ± 7.4 years; BMI 22.4 ± 2.3 kg/m2), matched for age and sex. Methods: HPA axis responsiveness was investigated using the combined dexamethasone/corticotropin-releasing hormone (dex/CRH) test, and curve indicators were derived for cortisol and adrenocorticotropic hormone (ACTH). The 5-HTT selective tracer [11C]DASB was applied, and parametric images of the binding potentials (BPND) were calculated using the multilinear reference tissue model and evaluated by atlas-based volume of interest (VOI) analysis. The self-questionnaires of behavioral inhibition system/behavioral activation system (BIS/BAS) with subscales drive, fun-seeking and reward were assessed. Results: OB showed significant positive correlations of ACTH curve parameters with overall 5-HTT BPND (ACTHAUC: r = 0.39, p = 0.04) and 5-HTT BPND of the caudate nucleus (ACTHAUC: r = 0.54, p = 0.003). In NO, cortisol indicators correlated significantly with BPND in the hippocampus (cortisolAUC: r = 0.59, p = 0.04). In OB, BAS reward was inversely associated with the ACTHAUC (r = −0.49, p = 0.009). Conclusion: The present study supports a serotonergic-neuroendocrine association, which regionally differs between OB and NO. In OB, areas processing emotion and reward seem to be in-volved. The finding of a serotonergic HPA correlation may have implications for other diseases with dysregulated stress axis responsiveness, and for potential pharmacologic interven-tions.
doi_str_mv 10.3390/brainsci12111430
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3846da0798974021a51035f2a1e05f62</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3846da0798974021a51035f2a1e05f62</doaj_id><sourcerecordid>2734609241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-3e5301ce9c688c20ab236686107923b9b96ca1fc1ff12fde7e05faf4c4182093</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEolXpnaMlLlwC_ooTX5CiFbCVKopg79bEcVqvsvbiSbZU6o-vwxZEa1myPfPOo9HrKYq3jH4QQtOPXQIf0HrGGWNS0BfFKae1KoXk1cv_7ifFOeKW5tVQKir6ujgRSlRN3qfF_fp7S9rfHskPh_sY0B9ccIikRYzWw-SQ3PrphqxcmBKM5KdLcYrBB7JJEHJJmlwi7QH8CJ0f_XRHcm497yCQq87hEoDQk28xlH_fq5hZccQ3xasBRnTnj-dZsfnyebNal5dXXy9W7WVpc7tTKVwlKLNOW9U0llPouFCqUYzWmotOd1pZYINlw8D40Lva0WqAQVrJGk61OCsujtg-wtbsk99BujMRvPkTiOnaQJq8HZ0RjVQ9ZG6ja0k5g4plywYObGEqnlmfjqz93O1cb4-uPIE-zQR_Y67jwejcuxQL4P0jIMVfs8PJ7DxaN44QXJzR8Dr_ixaSiix990y6jXMK2alFJRXVXLKsokeVTRExueFfM4yaZVDM80ERDyvWsdU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2734609241</pqid></control><display><type>article</type><title>HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Schinke, Christian ; Rullmann, Michael ; Luthardt, Julia ; Drabe, Mandy ; Preller, Elisa ; Becker, Georg A. ; Patt, Marianne ; Regenthal, Ralf ; Zientek, Franziska ; Sabri, Osama ; Then Bergh, Florian ; Hesse, Swen</creator><creatorcontrib>Schinke, Christian ; Rullmann, Michael ; Luthardt, Julia ; Drabe, Mandy ; Preller, Elisa ; Becker, Georg A. ; Patt, Marianne ; Regenthal, Ralf ; Zientek, Franziska ; Sabri, Osama ; Then Bergh, Florian ; Hesse, Swen</creatorcontrib><description>Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Objective: To investigate the relation of HPA responsiveness and serotonin transporter (5-HTT) availability in otherwise healthy individuals with obesity class II or III (OB) compared to non-obesity controls (NO). Study participants: Twenty-eight OB (21 females; age 36.6 ± 10.6 years; body mass index (BMI) 41.2 ± 5.1 kg/m2) were compared to 12 healthy NO (8 females; age 35.8 ± 7.4 years; BMI 22.4 ± 2.3 kg/m2), matched for age and sex. Methods: HPA axis responsiveness was investigated using the combined dexamethasone/corticotropin-releasing hormone (dex/CRH) test, and curve indicators were derived for cortisol and adrenocorticotropic hormone (ACTH). The 5-HTT selective tracer [11C]DASB was applied, and parametric images of the binding potentials (BPND) were calculated using the multilinear reference tissue model and evaluated by atlas-based volume of interest (VOI) analysis. The self-questionnaires of behavioral inhibition system/behavioral activation system (BIS/BAS) with subscales drive, fun-seeking and reward were assessed. Results: OB showed significant positive correlations of ACTH curve parameters with overall 5-HTT BPND (ACTHAUC: r = 0.39, p = 0.04) and 5-HTT BPND of the caudate nucleus (ACTHAUC: r = 0.54, p = 0.003). In NO, cortisol indicators correlated significantly with BPND in the hippocampus (cortisolAUC: r = 0.59, p = 0.04). In OB, BAS reward was inversely associated with the ACTHAUC (r = −0.49, p = 0.009). Conclusion: The present study supports a serotonergic-neuroendocrine association, which regionally differs between OB and NO. In OB, areas processing emotion and reward seem to be in-volved. The finding of a serotonergic HPA correlation may have implications for other diseases with dysregulated stress axis responsiveness, and for potential pharmacologic interven-tions.</description><identifier>ISSN: 2076-3425</identifier><identifier>EISSN: 2076-3425</identifier><identifier>DOI: 10.3390/brainsci12111430</identifier><identifier>PMID: 36358358</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Adrenocorticotropic hormone ; Alcohol ; Alzheimer's disease ; Body mass index ; Caudate nucleus ; Corticotropin-releasing hormone ; Cortisol ; Dexamethasone ; Hormones ; Hypothalamic-pituitary-adrenal axis ; hypothalamic–pituitary–adrenal axis (HPA) ; Hypothalamus ; Magnetic resonance imaging ; Mental depression ; Metabolic syndrome ; Obesity ; Pathogenesis ; Pituitary ; positron emission tomography (PET) ; Psychiatrists ; Reinforcement ; reward ; Serotonin ; Serotonin transporter ; serotonin transporter (5-HTT) ; Stress response</subject><ispartof>Brain sciences, 2022-10, Vol.12 (11), p.1430</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c350t-3e5301ce9c688c20ab236686107923b9b96ca1fc1ff12fde7e05faf4c4182093</cites><orcidid>0000-0002-7292-1859 ; 0000-0001-8604-8408 ; 0000-0003-1112-866X ; 0000-0002-0580-8872 ; 0000-0002-2683-9432</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2734609241/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2734609241?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids></links><search><creatorcontrib>Schinke, Christian</creatorcontrib><creatorcontrib>Rullmann, Michael</creatorcontrib><creatorcontrib>Luthardt, Julia</creatorcontrib><creatorcontrib>Drabe, Mandy</creatorcontrib><creatorcontrib>Preller, Elisa</creatorcontrib><creatorcontrib>Becker, Georg A.</creatorcontrib><creatorcontrib>Patt, Marianne</creatorcontrib><creatorcontrib>Regenthal, Ralf</creatorcontrib><creatorcontrib>Zientek, Franziska</creatorcontrib><creatorcontrib>Sabri, Osama</creatorcontrib><creatorcontrib>Then Bergh, Florian</creatorcontrib><creatorcontrib>Hesse, Swen</creatorcontrib><title>HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls</title><title>Brain sciences</title><description>Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Objective: To investigate the relation of HPA responsiveness and serotonin transporter (5-HTT) availability in otherwise healthy individuals with obesity class II or III (OB) compared to non-obesity controls (NO). Study participants: Twenty-eight OB (21 females; age 36.6 ± 10.6 years; body mass index (BMI) 41.2 ± 5.1 kg/m2) were compared to 12 healthy NO (8 females; age 35.8 ± 7.4 years; BMI 22.4 ± 2.3 kg/m2), matched for age and sex. Methods: HPA axis responsiveness was investigated using the combined dexamethasone/corticotropin-releasing hormone (dex/CRH) test, and curve indicators were derived for cortisol and adrenocorticotropic hormone (ACTH). The 5-HTT selective tracer [11C]DASB was applied, and parametric images of the binding potentials (BPND) were calculated using the multilinear reference tissue model and evaluated by atlas-based volume of interest (VOI) analysis. The self-questionnaires of behavioral inhibition system/behavioral activation system (BIS/BAS) with subscales drive, fun-seeking and reward were assessed. Results: OB showed significant positive correlations of ACTH curve parameters with overall 5-HTT BPND (ACTHAUC: r = 0.39, p = 0.04) and 5-HTT BPND of the caudate nucleus (ACTHAUC: r = 0.54, p = 0.003). In NO, cortisol indicators correlated significantly with BPND in the hippocampus (cortisolAUC: r = 0.59, p = 0.04). In OB, BAS reward was inversely associated with the ACTHAUC (r = −0.49, p = 0.009). Conclusion: The present study supports a serotonergic-neuroendocrine association, which regionally differs between OB and NO. In OB, areas processing emotion and reward seem to be in-volved. The finding of a serotonergic HPA correlation may have implications for other diseases with dysregulated stress axis responsiveness, and for potential pharmacologic interven-tions.</description><subject>Adrenocorticotropic hormone</subject><subject>Alcohol</subject><subject>Alzheimer's disease</subject><subject>Body mass index</subject><subject>Caudate nucleus</subject><subject>Corticotropin-releasing hormone</subject><subject>Cortisol</subject><subject>Dexamethasone</subject><subject>Hormones</subject><subject>Hypothalamic-pituitary-adrenal axis</subject><subject>hypothalamic–pituitary–adrenal axis (HPA)</subject><subject>Hypothalamus</subject><subject>Magnetic resonance imaging</subject><subject>Mental depression</subject><subject>Metabolic syndrome</subject><subject>Obesity</subject><subject>Pathogenesis</subject><subject>Pituitary</subject><subject>positron emission tomography (PET)</subject><subject>Psychiatrists</subject><subject>Reinforcement</subject><subject>reward</subject><subject>Serotonin</subject><subject>Serotonin transporter</subject><subject>serotonin transporter (5-HTT)</subject><subject>Stress response</subject><issn>2076-3425</issn><issn>2076-3425</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkk1v1DAQhiMEolXpnaMlLlwC_ooTX5CiFbCVKopg79bEcVqvsvbiSbZU6o-vwxZEa1myPfPOo9HrKYq3jH4QQtOPXQIf0HrGGWNS0BfFKae1KoXk1cv_7ifFOeKW5tVQKir6ujgRSlRN3qfF_fp7S9rfHskPh_sY0B9ccIikRYzWw-SQ3PrphqxcmBKM5KdLcYrBB7JJEHJJmlwi7QH8CJ0f_XRHcm497yCQq87hEoDQk28xlH_fq5hZccQ3xasBRnTnj-dZsfnyebNal5dXXy9W7WVpc7tTKVwlKLNOW9U0llPouFCqUYzWmotOd1pZYINlw8D40Lva0WqAQVrJGk61OCsujtg-wtbsk99BujMRvPkTiOnaQJq8HZ0RjVQ9ZG6ja0k5g4plywYObGEqnlmfjqz93O1cb4-uPIE-zQR_Y67jwejcuxQL4P0jIMVfs8PJ7DxaN44QXJzR8Dr_ixaSiix990y6jXMK2alFJRXVXLKsokeVTRExueFfM4yaZVDM80ERDyvWsdU</recordid><startdate>20221025</startdate><enddate>20221025</enddate><creator>Schinke, Christian</creator><creator>Rullmann, Michael</creator><creator>Luthardt, Julia</creator><creator>Drabe, Mandy</creator><creator>Preller, Elisa</creator><creator>Becker, Georg A.</creator><creator>Patt, Marianne</creator><creator>Regenthal, Ralf</creator><creator>Zientek, Franziska</creator><creator>Sabri, Osama</creator><creator>Then Bergh, Florian</creator><creator>Hesse, Swen</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7292-1859</orcidid><orcidid>https://orcid.org/0000-0001-8604-8408</orcidid><orcidid>https://orcid.org/0000-0003-1112-866X</orcidid><orcidid>https://orcid.org/0000-0002-0580-8872</orcidid><orcidid>https://orcid.org/0000-0002-2683-9432</orcidid></search><sort><creationdate>20221025</creationdate><title>HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls</title><author>Schinke, Christian ; Rullmann, Michael ; Luthardt, Julia ; Drabe, Mandy ; Preller, Elisa ; Becker, Georg A. ; Patt, Marianne ; Regenthal, Ralf ; Zientek, Franziska ; Sabri, Osama ; Then Bergh, Florian ; Hesse, Swen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-3e5301ce9c688c20ab236686107923b9b96ca1fc1ff12fde7e05faf4c4182093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adrenocorticotropic hormone</topic><topic>Alcohol</topic><topic>Alzheimer's disease</topic><topic>Body mass index</topic><topic>Caudate nucleus</topic><topic>Corticotropin-releasing hormone</topic><topic>Cortisol</topic><topic>Dexamethasone</topic><topic>Hormones</topic><topic>Hypothalamic-pituitary-adrenal axis</topic><topic>hypothalamic–pituitary–adrenal axis (HPA)</topic><topic>Hypothalamus</topic><topic>Magnetic resonance imaging</topic><topic>Mental depression</topic><topic>Metabolic syndrome</topic><topic>Obesity</topic><topic>Pathogenesis</topic><topic>Pituitary</topic><topic>positron emission tomography (PET)</topic><topic>Psychiatrists</topic><topic>Reinforcement</topic><topic>reward</topic><topic>Serotonin</topic><topic>Serotonin transporter</topic><topic>serotonin transporter (5-HTT)</topic><topic>Stress response</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schinke, Christian</creatorcontrib><creatorcontrib>Rullmann, Michael</creatorcontrib><creatorcontrib>Luthardt, Julia</creatorcontrib><creatorcontrib>Drabe, Mandy</creatorcontrib><creatorcontrib>Preller, Elisa</creatorcontrib><creatorcontrib>Becker, Georg A.</creatorcontrib><creatorcontrib>Patt, Marianne</creatorcontrib><creatorcontrib>Regenthal, Ralf</creatorcontrib><creatorcontrib>Zientek, Franziska</creatorcontrib><creatorcontrib>Sabri, Osama</creatorcontrib><creatorcontrib>Then Bergh, Florian</creatorcontrib><creatorcontrib>Hesse, Swen</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Brain sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schinke, Christian</au><au>Rullmann, Michael</au><au>Luthardt, Julia</au><au>Drabe, Mandy</au><au>Preller, Elisa</au><au>Becker, Georg A.</au><au>Patt, Marianne</au><au>Regenthal, Ralf</au><au>Zientek, Franziska</au><au>Sabri, Osama</au><au>Then Bergh, Florian</au><au>Hesse, Swen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls</atitle><jtitle>Brain sciences</jtitle><date>2022-10-25</date><risdate>2022</risdate><volume>12</volume><issue>11</issue><spage>1430</spage><pages>1430-</pages><issn>2076-3425</issn><eissn>2076-3425</eissn><abstract>Background: Alterations of hypothalamic–pituitary–adrenal (HPA) axis activity and serotonergic signaling are implicated in the pathogenesis of human obesity and may contribute to its metabolic and mental complications. The association of these systems has not been investigated in human obesity. Objective: To investigate the relation of HPA responsiveness and serotonin transporter (5-HTT) availability in otherwise healthy individuals with obesity class II or III (OB) compared to non-obesity controls (NO). Study participants: Twenty-eight OB (21 females; age 36.6 ± 10.6 years; body mass index (BMI) 41.2 ± 5.1 kg/m2) were compared to 12 healthy NO (8 females; age 35.8 ± 7.4 years; BMI 22.4 ± 2.3 kg/m2), matched for age and sex. Methods: HPA axis responsiveness was investigated using the combined dexamethasone/corticotropin-releasing hormone (dex/CRH) test, and curve indicators were derived for cortisol and adrenocorticotropic hormone (ACTH). The 5-HTT selective tracer [11C]DASB was applied, and parametric images of the binding potentials (BPND) were calculated using the multilinear reference tissue model and evaluated by atlas-based volume of interest (VOI) analysis. The self-questionnaires of behavioral inhibition system/behavioral activation system (BIS/BAS) with subscales drive, fun-seeking and reward were assessed. Results: OB showed significant positive correlations of ACTH curve parameters with overall 5-HTT BPND (ACTHAUC: r = 0.39, p = 0.04) and 5-HTT BPND of the caudate nucleus (ACTHAUC: r = 0.54, p = 0.003). In NO, cortisol indicators correlated significantly with BPND in the hippocampus (cortisolAUC: r = 0.59, p = 0.04). In OB, BAS reward was inversely associated with the ACTHAUC (r = −0.49, p = 0.009). Conclusion: The present study supports a serotonergic-neuroendocrine association, which regionally differs between OB and NO. In OB, areas processing emotion and reward seem to be in-volved. The finding of a serotonergic HPA correlation may have implications for other diseases with dysregulated stress axis responsiveness, and for potential pharmacologic interven-tions.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36358358</pmid><doi>10.3390/brainsci12111430</doi><orcidid>https://orcid.org/0000-0002-7292-1859</orcidid><orcidid>https://orcid.org/0000-0001-8604-8408</orcidid><orcidid>https://orcid.org/0000-0003-1112-866X</orcidid><orcidid>https://orcid.org/0000-0002-0580-8872</orcidid><orcidid>https://orcid.org/0000-0002-2683-9432</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2076-3425
ispartof Brain sciences, 2022-10, Vol.12 (11), p.1430
issn 2076-3425
2076-3425
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3846da0798974021a51035f2a1e05f62
source Publicly Available Content Database; PubMed Central
subjects Adrenocorticotropic hormone
Alcohol
Alzheimer's disease
Body mass index
Caudate nucleus
Corticotropin-releasing hormone
Cortisol
Dexamethasone
Hormones
Hypothalamic-pituitary-adrenal axis
hypothalamic–pituitary–adrenal axis (HPA)
Hypothalamus
Magnetic resonance imaging
Mental depression
Metabolic syndrome
Obesity
Pathogenesis
Pituitary
positron emission tomography (PET)
Psychiatrists
Reinforcement
reward
Serotonin
Serotonin transporter
serotonin transporter (5-HTT)
Stress response
title HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A24%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPA%20Axis%20Responsiveness%20Associates%20with%20Central%20Serotonin%20Transporter%20Availability%20in%20Human%20Obesity%20and%20Non-Obesity%20Controls&rft.jtitle=Brain%20sciences&rft.au=Schinke,%20Christian&rft.date=2022-10-25&rft.volume=12&rft.issue=11&rft.spage=1430&rft.pages=1430-&rft.issn=2076-3425&rft.eissn=2076-3425&rft_id=info:doi/10.3390/brainsci12111430&rft_dat=%3Cproquest_doaj_%3E2734609241%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-3e5301ce9c688c20ab236686107923b9b96ca1fc1ff12fde7e05faf4c4182093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2734609241&rft_id=info:pmid/36358358&rfr_iscdi=true